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ABSTRACT 
Objective: To develop and validate robust, accurate and precise UV spectrophotometric method for determination of Ketorolac Tromethamine and 
Phenylephrine Hydrochloride.  
Methods: Ratio spectra derivative method was developed using water as solvent. The developed method was validated as per International 
Conference on Harmonization (ICH) guidelines. 
Results: Linearity of the developed method was 0.9958 and 0.9987 in the range of 4-20 ppm and 12-60 ppm for Ketorolac Tromethamine and 
Phenylephrine Hydrochloride respectively. % Relative standard deviation (RSD) was found to be less than 2 for Intraday precision and Intermediate 
precision. % recovery was found to be 98.5–100.27 % and 98.38–101.99 % for Ketorolac Tromethamine and Phenylephrine Hydrochloride 
respectively.  
Conclusion: A robust, accurate and precise UV spectrophotometric method was developed and validated as per ICH guidelines. 
Keywords: Ketorolac Tromethamine, Phenylephrine Hydrochloride, UV spectroscopy, Ratio spectra derivative method. 
 
INTRODUCTION 
Ketorolac Tromethamine, chemically known as 5-benzoyl-2,3-
dihydro-1H-pyrrolizine-1-carboxylic acid with 2-amino-2-
(hydroxymethyl) propane-1,3-diol (fig. 1), is a Non-steroidal anti-
inflammatory drug. Ketorolac Tromethamine is used as an analgesic 
and antipyretic agent. It is freely soluble in water and methanol.  
Ketorolac Tromethamine is official in IP, BP and USP and estimated 
by Potentiometric Titration as per IP [1] and BP [2] and HPLC as per 
USP [3]. Literature survey showed several reported spectro-
photometric [4, 5] and HPLC [6, 7] methods for determination of 
Ketorolac Tromethamine in pharmaceutical dosage form either as 
the single component or in combination with other drugs. 
Phenylephrine Hydrochloride, chemically known as R)-1-(3-
Hydroxy phenyl)-2-methyl amino ethanol hydrochloride (fig. 2), is a 
sympathomimetic drug. Phenylephrine Hydrochloride is used as an 
anti-allergic agent. It is freely soluble in water and methanol 
[8].Phenylephrine Hydrochloride is official in IP, BP and USP and 
estimated by potentiometric titration as per IP [9] and BP [10] and 
Titration as per USP [11]. 
 
  
Fig. 1: Structure of ketorolac tromethamine Fig. 2: Structure of phenylephrine hydrochloride 
 
Literature survey showed several reported spectrophotometric 
[12, 13] and HPLC [14, 15] methods for determination of 
Phenylephrine Hydrochloride in pharmaceutical dosage form 
either as the single component or in combination with other drugs 
[16, 17]. There are no UV methods available for simultaneous 
estimation of Ketorolac Tromethamine and Phenylephrine 
Hydrochloride in combination. 
So the rational this works to develop robust, accurate and precise UV 
method for simultaneous estimation of Ketorolac Tromethamine and 
Phenylephrine Hydrochloride in immediate release tablet. 
MATERIALS AND METHODS 
Materials 
Instrument 
UV visible spectrophotometer (Shimadzu, model 1800) with UV 
probe software was used for recording the spectra and measuring 
the absorbance. 
Chemicals and reagents 
Ketorolac Tromethamine was supplied by the Cadila healthcare, 
Ahmedabad as the gift sample. Phenylephrine Hydrochloride was 
supplied by the Tuton Pharmaceuticals, Mumbai as the gift sample. 
For the preparation of solution double distill water was used. 
Methods 
Selection of solvent 
Double distil water was used as a solvent for the preparation of the 
sample solution. 
Selection of method 
Standard solution of Ketorolac Tromethamine (4.2 µg/ml) and 
Phenylephrine Hydrochloride (12.6 µg/ml) was scanned separately 
in the range of 200-400 nm. From the overlay spectra of Ketorolac 
Tromethamine and Phenylephrine Hydrochloride, Absorbance 
correction method, Absorbance ratio and derivative spectroscopic 
International Journal of Pharmacy and Pharmaceutical Sciences 
ISSN- 0975-1491                Vol 7, Issue 11, 2015 
Innovare 
Academic Sciences 
Parmar et al. 
Int J Pharm Pharm Sci, Vol 7, Issue 11, 13-16 
14 
method are possible. But in all these methods % recovery was found 
out of the limit. So that Ratio spectra derivative spectroscopic 
method was developed. 
 
 
Fig. 3: Overlay spectra of ketorolac tromethamine and 
phenylephrine hydrochloride 
 
Ratio spectra derivative spectroscopic method 
Selection of wavelength 
4µg/ml of Ketorolac Tromethamine and 12µg/ml Phenylephrine 
Hydrochloride were scanned separately in the range of 200-400 nm. 
For this method development, Ketorolac Tromethamine (12 µg/ml) 
and Phenylephrine Hydrochloride (36 µg/ml) were used as devisor 
and first derivative spectra were traced using 1 scaling factor. From 
the first derivative ratio spectra, 290 nm selected for the Ketorolac 
Tromethamine (fig. 4) and 227 nm selected for the Phenylephrine 
Hydrochloride (fig. 5). 
Preparation of stock solution for ketorolac tromethamine  
(100 µg/ml) 
A stock solution of 100 µg/ml of Ketorolac Tromethamine was 
prepared by accurately weighing 10 mg of Ketorolac Tromethamine 
and transferred in 100 ml volumetric flasks. 50 ml of water was 
added in the volumetric flask and the drug was dissolved properly 
and then the volume was made up to 100 ml with water. 
Preparation of stock solution for phenylephrine hydrochloride 
(100 µg/ml) 
A stock solution of 100 µg/ml of Phenylephrine Hydrochloride was 
prepared by accurately weighing 10 mg of Phenylephrine 
Hydrochloride and transferred in a 100 ml volumetric flask. 50 ml of 
water was added in the volumetric flask and the drug was dissolved 
properly and then the volume was made up to 100 ml with water. 
Preparation of sample solution  
Twenty tablets were weighed; average weight was determined and 
finely powdered. An accurately weighed quantity of tablet powder 
equivalent to 4.2 mg Ketorolac Tromethamine and 12.6 mg 
Phenylephrine Hydrochloride was transferred to 100 ml volumetric 
flask and 50 ml of water was added and dissolved by sonication for 
30 min and then volume up was made up to the mark with water. 
Then solution is filtered through whatman filter paper. 1 ml of 
filtrate was taken in a 10 ml of volumetric flask and volume was 
made up to mark with water. The above mixture was analysed in UV 
spectrophotometer. % assay was calculated. Results are reported in 
table 6. 
RESULTS AND DISCUSSION 
Selection of wavelength 
4µg/ml of Ketorolac Tromethamine and 12µg/ml Phenylephrine 
Hydrochloride were scanned separately in the range of 200-400 nm. 
For this method development Ketorolac Tromethamine (12 µg/ml) 
and Phenylephrine Hydrochloride (36 µg/ml) were used as devisor 
and first derivative spectra were traced using 1 scaling factor. From 
the first derivative ratio spectra, wavelength selected were 290 nm 




Fig. 4: First derivative ratio spectra of Phenylephrine 




Fig. 5: First derivative ratio spectra of ketorolac tromethamine 
(4 µg/ml), divisor phenylephrine hydrochloride (36 µg/ml) 
 
Validation of ratio spectra derivative spectroscopic method 
Linearity and range 
Linearity study was carried out for both the drugs at different 
concentration levels. Linearity of Ketorolac Tromethamine and 
Phenylephrine Hydrochloride was in the range of 4-20 µg/ml and 
12-60 µg/ml and results are reported in following table. 
 
 
Fig. 6: Calibration curve for ketorolac tromethamine at 290 nm 
Parmar et al. 
Int J Pharm Pharm Sci, Vol 7, Issue 11, 13-16 
15 
 





Three replicates of three concentration of standard solution of 
Ketorolac Tromethamine (8, 12 and 16 µg/ml) and Phenylephrine 
Hydrochloride (24, 36 and 48 µg/ml), total nine determination were 
analysed at three consecutive times on same day and absorbance 
was measured. % RSD was found to be within acceptable limit that 
is<2 %. The data for intraday precision of are reported in table 2. 
Intermediate precision 
Inter day precision 
Three replicates of three concentration of standard solution of 
Ketorolac Tromethamine (8, 12 and 16 µg/ml) and Phenylephrine 
Hydrochloride (24, 36 and 48 µg/ml), total nine determination were 
analysed at three consecutive day and absorbance was measured. % 
RSD was found to be within acceptable limit that is<2 %. The data 
for inter day precision of are reported in table 2. 
Different instruments 
Three concentration of standard solution of Ketorolac 
Tromethamine (8, 12 and 16 µg/ml) and Phenylephrine 
Hydrochloride (24, 36 and 48 µg/ml) were analysed by two different 
instruments (UV-1800 and UV-1700) on a single day and absorbance 
was measured. % RSD was found to be within acceptable limit that 
is<2 %. The data are reported in table 2. 
Different analysts 
Three concentrations of the standard solution of Ketorolac 
Tromethamine (8, 12 and 16 µg/ml) and Phenylephrine 
Hydrochloride (24, 36 and 48 µg/ml) were analysed by three 
different analysts and absorbance was measured. % RSD was found 
to be within acceptable limit that is<2 %. The data for different 
analyst are reported in table 2. 
 
Table1: Data for linearity and range 
Ketorolac tromethamine Phenylephrine hydrochloride 
Concentration (µg/ml) Response at 290 nm (n=5) Concentration (µg/ml) Response at 227 nm (n=5) 
4 0.330 12 -0.131 
8 0.632 24 -0.253 
12 0.812 36 -0.386 
16 1.075 48 -0.491 
20 1.337 60 -0.629 
Regression equation y = 0.0614x+0.1005 Regression equation y =-0.0103x-0.0078 
R2 0.9958  value R2 0.9987 value 
 
Table 2: Precision data for ketorolac tromethamine and phenylephrine hydrochloride 









Intraday precision (n=3) 8 24 0.34 0.37 
12 36 0.09 0.52 
16 48 0.11 1.00 
Inter day precision (n=3) 8 24 0.78 0.81 
12 36 1.20 0.80 
16 48 0.16 1.28 
Different instrument 
precision (n=2) 
8 24 0.55 0.78 
12 36 0.74 0.64 
16 48 0.42 1.00 
Different analyst precision 
(n=3) 
8 24 0.94 0.67 
12 36 1.16 1.06 
16 48 0.33 0.58 
 
Table 3: Accuracy data for ketorolac tromethamine and phenylephrine hydrochloride 
Level % Recovery 
Ketorolac tromethamine Phenylephrine hydrochloride 
80 % (n=3) 100.17 99.51 
100 % (n=3) 98.87 100.37 
120 % (n=3) 100.20 100.50 
 
Accuracy 
Accuracy study was performed using the placebo. The accuracy of 
the method was tested by 3 replicate analyses of 3 different levels 
(80%, 100% and 120%). Accuracy was determined by % recovery 
study. % recovery was found to be 98.19–100.71 % and 98.50–
101.72% for Ketorolac Tromethamine and Phenylephrine 
Hydrochloride respectively. The data of accuracy are reported in 
following table. 
Limit of detection (LOD) and limit of quantitation (LOQ) 
LOD and LOQ were determined by repeating the calibration curve five 
times. The results of LOD and LOQ are reported in following table.
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Table 4: Data of LOD and LOQ 
Parameter Ketorolac tromethamine Phenylephrine hydrochloride 
S. D. of five intercept 0.01703 0.00133 
Mean of five slope 0.215 0.0102 
LOD(µg/ml) 0.261 0.433 
LOQ(µg/ml) 0.792 1.30 
 
Table 5: Robustness data for ketorolac tromethamine and phenylephrine hydrochloride 
Drug Concentration (µg/ml) % RSD 
Ketorolac tromethamine 8 0.91 
12 1.57 
16 1.36 




Table 6: Data for analysis of IR tablet by UV method 
Tablet Dose Amount found (mg) (mean±SD) (n=3) % amount found (mean±SD) (n=3) 
Ketorolac tromethamine 4.2 mg 4.21±0.02 100.36±0.59 
Phenylephrine hydrochloride 12.6 mg 12.73±0.19 99.53 ±1.51 
 
Robustness 
Three concentrations of the standard solution of Ketorolac 
Tromethamine (8, 12 and 16 µg/ml) and Phenylephrine 
Hydrochloride (24, 36 and 48 µg/ml) were analysed at 3 different 
wave length and % RSD was calculated. % RSD was found to be 
within acceptable limit that is <2 %. The data for Robustness 
(different wavelength) are reported in the following table. 
Analysis of drugs in immediate release tablet 
Analysis of drugs in immediate release (IR) tablet was done by UV 
method and the % Assay was calculated. % amount of both the drug 
was found within the limit that is 98-102%. 
CONCLUSION 
In present work, ratio spectra derivative spectroscopic method was 
developed for simultaneous estimation of Ketorolac Tromethamine 
and Phenylephrine Hydrochloride in using water as a solvent. The 
developed method is robust, accurate and precise. The method is 
successfully validated as per ICH guidelines.  
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